Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Fíguls

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Reumatologia Clinica|July 29, 2011
[Sjögren's Syndrome]Hèctor Corominas, Ramon Fíguls, Manel Riera
Reumatologia Clinica|September 20, 2011
[Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases]Lucinda Sánchez-Eslava, Hèctor Corominas, Manel Riera, et al.
Expert Opinion on Biological Therapy|March 27, 2012
"Switching adalimumab from syringe to pen. Expected outcomes"Hèctor Corominas, Silvia Garcia-Diaz, Lucinda Sanchez-Eslava, et al.
Reumatologia Clinica|April 10, 2012
AcromegalyDacia Cerdà Gabaroi, Hèctor Corominas Macías, Delia Reina Sanz, et al.
Reumatologia Clinica|July 4, 2012
Sweet syndrome associated with myelodysplastic syndrome: report of a case. Review of the literatureDelia Reina, Dacia Cerdà, Daniel Roig, et al.
Enfermeria Clinica|August 7, 2013
[Preference for etanercept pen versus syringe in patients with chronic arthritis. Nurse education workshop]Silvia Garcia-Diaz, Montserrat Girabent-Farrés, Daniel Roig-Vilaseca, et al.
Reumatologia Clinica|September 13, 2015
Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT studyHèctor Corominas, Javier Narváez, César Díaz-Torné, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Reumatologia Clinica|July 29, 2011
[Sjögren's Syndrome]Hèctor Corominas, Ramon Fíguls, Manel Riera
Reumatologia Clinica|September 20, 2011
[Experience of monitoring subcutaneous biological treatment (adalimumab) by nurses in chronic inflammatory diseases]Lucinda Sánchez-Eslava, Hèctor Corominas, Manel Riera, et al.
Expert Opinion on Biological Therapy|March 27, 2012
"Switching adalimumab from syringe to pen. Expected outcomes"Hèctor Corominas, Silvia Garcia-Diaz, Lucinda Sanchez-Eslava, et al.
Reumatologia Clinica|April 10, 2012
AcromegalyDacia Cerdà Gabaroi, Hèctor Corominas Macías, Delia Reina Sanz, et al.
Reumatologia Clinica|July 4, 2012
Sweet syndrome associated with myelodysplastic syndrome: report of a case. Review of the literatureDelia Reina, Dacia Cerdà, Daniel Roig, et al.
Enfermeria Clinica|August 7, 2013
[Preference for etanercept pen versus syringe in patients with chronic arthritis. Nurse education workshop]Silvia Garcia-Diaz, Montserrat Girabent-Farrés, Daniel Roig-Vilaseca, et al.
Reumatologia Clinica|September 13, 2015
Diagnostic and therapeutic delay of rheumatoid arthritis and its relationship with health care devices in Catalonia. The AUDIT studyHèctor Corominas, Javier Narváez, César Díaz-Torné, et al.
Pageof 1